ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

The Effiency and Safety of Chemotherapy for Urothelial Carcinoma in Post-Kidney Transplanted Patients.

Y. Zhu, J. Lin.

Urology, Capital Medical University Beijing Friendship Hospital, Beijing, China

Meeting: 2017 American Transplant Congress

Abstract number: C262

Keywords: Kidney transplantation, Malignancy

Session Information

Date: Monday, May 1, 2017

Session Name: Poster Session C: PTLD/Malignancies

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Hall D1

Related Abstracts
  • Adjuvant Chemotherapy with Gemcitabine Plus Cisplatin for Kidney Transplant Patients with Transitional Cell Carcinoma.
  • Incidence, Recurrence and Long Term Survival Post Chemotherapy in Renal Transplant Recipients with Post Transplant Lymphoproliferative Disorder: Single Center Study.

Objective: According to our published data, upper tract urothelial carcinoma (UTUC) is the predominant malignancy among Chinese renal transplanted patients. This is quite different from western countries in which non-melanoma skin cancer and post-transplant lymphoproliferative disorder (PTLD) are the most common malignancy. Although the surgical intervention is recommended, due to the fast progression, post-transplant UTUC is always intractable and has poor prognosis. Present study is to assess the safety and the efficacy of platinum-based chemotherapy (CT) in renal transplant (RT) patients with muscle invasive UTUC (MIUTUC).

Methods: We retrospectively reviewed the records of 29 RT patients with MIUTUC who regularly followed up in our hospital since January 2002. All patients received radical nephroureterectomy (RU), then was treated with gemcitabine (800 mg/m2) plus cisplatin (70 mg/m2)/carboplatin (AUC=5) every 28 days or only regularly followed up.

Results: 14 patients received adjuvant chemotherapy 1 month after RU (Group I), and the other 15 patients treated with RU only was grouped as control (Group II). Comparing group I and II, the baseline of demographic and oncologic data was no different. In group I, 14 patients received a median of four cycles' chemotherapy, the most common toxicities were myelosuppression and gastrointestinal effects and no severe renal and urinary disorder was observed. Disease-free rate for Group I & II was 54.3% and 26.7% at 2 years. Disease-free survival (DFS) of the patients treated with chemotherapy was better than those treated by RU only. Conclusion: The CT was shown to be effective and tolerable in RT patients with MIUTUC. Platinum-based CT regimen was safe for transplanted kidney function. Further studies involving more patients and long-term overall survival are required.

CITATION INFORMATION: Zhu Y, Lin J. The Effiency and Safety of Chemotherapy for Urothelial Carcinoma in Post-Kidney Transplanted Patients. Am J Transplant. 2017;17 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Zhu Y, Lin J. The Effiency and Safety of Chemotherapy for Urothelial Carcinoma in Post-Kidney Transplanted Patients. [abstract]. Am J Transplant. 2017; 17 (suppl 3). https://atcmeetingabstracts.com/abstract/the-effiency-and-safety-of-chemotherapy-for-urothelial-carcinoma-in-post-kidney-transplanted-patients/. Accessed April 22, 2021.

« Back to 2017 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time

        Visit Our Partner Sites

        American Transplant Congress (ATC)

        Visit the official site for the American Transplant Congress »

        American Journal of Transplantation

        The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

        American Society of Transplantation (AST)

        An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

        American Society of Transplant Surgeons (ASTS)

        The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

        Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

        Privacy Policy | Terms of Use

        loading Cancel
        Post was not sent - check your email addresses!
        Email check failed, please try again
        Sorry, your blog cannot share posts by email.
        This site uses cookies: Find out more.